期刊文献+

厄洛替尼对核转录因子κB表达以及单核细胞凋亡的影响 被引量:2

下载PDF
导出
摘要 目的研究厄洛替尼对单核细胞分化发育过程中核转录因子(NF)κB表达和凋亡的影响。方法分别在单核细胞系的培养液中加入EGF、厄洛替尼、EGF+厄洛替尼处理,Western印迹检测NF-κB的表达情况,流式细胞学检测单核细胞的凋亡率。结果厄洛替尼对人单核细胞的凋亡具有抑制作用,其抑制作用具有明显的剂量和时间依赖性(P<0.05);各组单核细胞的凋亡率差异有统计学意义(P<0.05);厄洛替尼可以显著地抑制单核细胞分泌NF-κB。结论厄洛替尼可以有效抑制单核细胞凋亡和迁移,进而调控单核细胞的分化。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第15期3693-3694,共2页 Chinese Journal of Gerontology
  • 相关文献

参考文献8

  • 1Hume DA,Ross IL,Himes SR,et al.The mononuclear phagocyte system revisited[J].J Leukoc Biol,2002;72(4):621-7.
  • 2Saito S,Nakayama T,Hashimoto N,et al.Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CCL2 greatly attenuate bleomycin-induced lung damage[J].Am J Pathol,2011;179(3):1088-94.
  • 3Storozynsky E,Woodward JG,Frelinger JG,et al.Interleukin-3 and gran-ulocyte-macrophage colony-stimulating factor enhance the generation and function of dendritic cells[J].Immunology,1999;97(1):138-49.
  • 4Sallusto F,NicolòC,De Maria R,et al.Ceramide inhibits antigen uptake and presentation by dendritic cells[J].J Exp Med,1996;184(6):2411-6.
  • 5Chomarat P,Dantin C,Bennett L,et al.TNF skews monocyte differentia-tion from macrophages to dendritic cells[J].J Immunol,2003;171(5):2262-9.
  • 6Egan LJ,Toruner M.NF-κB signaling:pros and cons of altering NF-κB as a therapeutic approach[J].Ann N Y Acad Sei,2006;1072(8):114-22.
  • 7黄虎,胡义德,栗娜.NF-κB、cyclin D1和p27在非小细胞肺癌中的表达及意义[J].现代肿瘤医学,2008,16(5):737-740. 被引量:5
  • 8王林,陈红,王原,杜改萍,陈银苹,俞亮科,孙晓东.吉非替尼对脐带来源间充质干细胞表达MCP-1的抑制作用[J].中国老年学杂志,2011,31(24):4788-4789. 被引量:1

二级参考文献23

  • 1Reagan MR, Kaplan DL. Concise review : Mesenchymal stem cell tumorhoming: detection methods in disease model systems [ J ]. Stem Cells, 2011 ;29(6) :920-7.
  • 2Saito S, Nakayama T, Hashimoto N, et al. Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CC12 greatly attenuate bleomycin-induced lung damage[ J]. Am J Pathol,2011 ; 179 (3) :1088- 94.
  • 3Lu LL, Liu Y J, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials[J]. Haematologica, 2006 ;91 ( 8 ) : 1017-26.
  • 4Normanno N, De Luca A, Aldinucci D ,et al. Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation : implications for the pathogenesis and treatment of bone metastasis [J]. Endocr Relat Cancer,2005 ; 12 ( 2 ) :471-82.
  • 5Giaccone G, Wang Y. Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors [ J ]. Cancer Treat Rev,2011 ;37 ( 6 ) :456-64.
  • 6Gridelli C, De Marinis F, Di Maio M, et al. Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation:Review of the evidence[ J]. Lung Cancer,2011 ;71 ( 3 ) :249-57.
  • 7Deshmane SL, Kremlev S, Amini S, et al. Monocyte chemoattractant protein-1 ( MCP-1 ) : an overview [ J ]. J Interferon Cytokine Res, 2009 ; 29 (6) :313-26.
  • 8Laurence J,Murat T. NF - B signaling pros and cons of altering NF -κB as a therapeutic approach [ J ]. Ann N Y Acad Sci,2006,1072: 114-122.
  • 9Tang X, Liu D, Shishodia S, et al. Nuclear factor - kappaB ( NF - kappaB) is frequently expressed in lung cancer and preneoplastic lesions [ J ]. Cancer, 2006,107 ( 11 ) : 2637 - 2646.
  • 10Catherine R, Murphy A, Pamela M, et al. CXCR2/NF - kappaB/ Bcl- 2 -survivin signalling pathway promotes resistance to oxaliplatin in metastatic prostate cancer cells [ J ]. Proe Amer Assoc Cancer Res, 2006,47 : 880.

共引文献4

同被引文献15

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部